TNX-102 SL, a sublingual cyclobenzaprine HCl formulation, is safe and effective for treating fibromyalgia symptoms, according to study results presented at the American College of Rheumatology (ACR) ...
Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, held November 14-19, 2024, in ...
(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the ACR Convergence 2024 Annual Meeting showcasing the success of its Phase 3 RESILIENT study for TNX-102 SL, a ...
A former security officer with fibromyalgia was unable to convince the First Circuit that the Transportation Security ...